Global Irritable Bowel Syndrome (IBS) Market Research Report 2011-2023
- HEY2360522
- 84 Pages
- January 2018
- Healthcare
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
IBS-D Drug
IBS-C Drug
Other
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Valeant Pharmaceuticals
Allergan
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Women
Men
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 IBS-D Drug
1.2.1.2 IBS-C Drug
1.2.1.3 Other
1.2.2 by Application
1.2.2.1 Women
1.2.2.2 Men
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 IBS-D Drug Market, 2011-2016
4.1.2 IBS-C Drug Market, 2011-2016
4.1.3 Other Market, 2011-2016
4.2 Market Forecast
4.2.1 IBS-D Drug Market Forecast, 2017-2022
4.2.2 IBS-C Drug Market Forecast, 2017-2022
4.2.3 Other Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Women Market, 2011-2016
5.1.2 Men Market, 2011-2016
5.2 Market Forecast
5.2.1 Women Market Forecast, 2017-2022
5.2.2 Men Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Valeant Pharmaceuticals
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Allergan
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Takeda
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Sucampo Pharmaceuticals
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 McNeil Consumer Healthcare
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Sebela Pharmaceuticals
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Astellas Pharmaceuticals
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 IM HealthScience
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion
List Of Tables
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Table Products Segment of Irritable Bowel Syndrome (IBS)
Table IBS-D Drug Overview
Table IBS-C Drug Overview
Table Other Overview
Table Global Irritable Bowel Syndrome (IBS) Market by Type, 2011-2022 (USD Million)
Table Application Segment of Irritable Bowel Syndrome (IBS)
Table Women Overview
Table Men Overview
Table Global Irritable Bowel Syndrome (IBS) Market by Application, 2011-2022 (USD Million)
Table Global Irritable Bowel Syndrome (IBS) Market by Region, 2011-2022 (USD Million)
Table Cost of Irritable Bowel Syndrome (IBS)
Table Market Dynamics
Table Policy of Irritable Bowel Syndrome (IBS)
Table GDP of Major Countries
Table IBS-D Drug CAGR by Revenue and Volume, 2011-2016
Table IBS-C Drug CAGR by Revenue and Volume, 2011-2016
Table Other CAGR by Revenue and Volume, 2011-2016
Table IBS-D Drug CAGR by Revenue and Volume, 2012-2022
Table IBS-C Drug CAGR by Revenue and Volume, 2012-2022
Table Other CAGR by Revenue and Volume, 2012-2022
Table Women CAGR by Revenue and Volume, 2011-2016
Table Men CAGR by Revenue and Volume, 2011-2016
List Of Figures
Figure Irritable Bowel Syndrome (IBS) Picture
Figure Industry Chain Structure of Irritable Bowel Syndrome (IBS)
Figure SWOT of Irritable Bowel Syndrome (IBS)
Figure IBS-D Drug Market Size and Growth, 2011-2016 (USD Million)
Figure IBS-D Drug Market Size and Growth, 2011-2016 (in Volume)
Figure IBS-C Drug Market Size and Growth, 2011-2016 (USD Million)
Figure IBS-C Drug Market Size and Growth, 2011-2016 (in Volume)
Figure Other Market Size and Growth, 2011-2016 (USD Million)
Figure Other Market Size and Growth, 2011-2016 (in Volume)
Figure IBS-D Drug Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure IBS-D Drug Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure IBS-C Drug Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure IBS-C Drug Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Other Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Other Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Women Market Size and Growth, 2011-2016 (USD Million)
Figure Women Market Size and Growth, 2011-2016 (in Volume)
Figure Men Market Size and Growth, 2011-2016 (USD Million)
Figure Men Market Size and Growth, 2011-2016 (in Volume)
Figure Women Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Women Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Men Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Men Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Irritable Bowel Syndrome (IBS) Market Concentration by Region
Figure Marketing Channels Overview
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
